Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76501 - 76525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamibarotene	Investigational	LY6E	4061	upregulated	tamibarotene results in increased expression of LY6E mRNA	8q24.3	A24376
Tamibarotene	Investigational	LYN	4067	upregulated	tamibarotene results in increased expression of LYN mRNA	8q12.1	A24376
Tamibarotene	Investigational	LZTFL1	54585	upregulated	tamibarotene results in increased expression of LZTFL1 mRNA	3p21.31	A20516
Tamibarotene	Investigational	MAP4K1	11184	upregulated	tamibarotene results in increased expression of MAP4K1 mRNA	19q13.1-q13.4	A20516
Tamibarotene	Investigational	MAPKAPK2	9261	upregulated	tamibarotene results in increased expression of MAPKAPK2 mRNA	1q32.1	A20516
Tamibarotene	Investigational	MAT2A	4144	downregulated	tamibarotene results in decreased expression of MAT2A mRNA	2p11.2	A24376
Tamibarotene	Investigational	MDK	4192	upregulated	tamibarotene results in increased expression of MDK mRNA	11p11.2	A20516
Tamibarotene	Investigational	MDM1	56890	downregulated	tamibarotene results in decreased expression of MDM1 mRNA	12q15	A24376
Tamibarotene	Investigational	MFGE8	4240	upregulated	tamibarotene results in increased expression of MFGE8 mRNA	15q26.1	A20516
Tamibarotene	Investigational	MGEA5	10724	downregulated	tamibarotene results in decreased expression of MGEA5 mRNA	10q24.32	A24376
Tamibarotene	Investigational	MORC2	22880	downregulated	tamibarotene results in decreased expression of MORC2 mRNA	22q12.2	A24376
Tamibarotene	Investigational	MSH6	2956	downregulated	tamibarotene results in decreased expression of MSH6 mRNA	2p16.3	A24376
Tamibarotene	Investigational	MT1A	4489	upregulated	tamibarotene results in increased expression of MT1A mRNA	16q13	A24376
Tamibarotene	Investigational	MTA1	9112	downregulated	tamibarotene results in decreased expression of MTA1 mRNA	14q32.33	A24376
Tamibarotene	Investigational	MTMR6	9107	downregulated	tamibarotene results in decreased expression of MTMR6 mRNA	13q12.13	A24376
Tamibarotene	Investigational	MYC	4609	downregulated	tamibarotene results in decreased expression of MYC mRNA	8q24.21	A24376
Tamibarotene	Investigational	MYD88	4615	upregulated	tamibarotene results in increased expression of MYD88 mRNA	3p22.2	A24376
Tamibarotene	Investigational	N4BP2L2	10443	downregulated	tamibarotene results in decreased expression of N4BP2L2 mRNA	13q13.1	A24376
Tamibarotene	Investigational	NAP1L1	4673	downregulated	tamibarotene results in decreased expression of NAP1L1 mRNA	12q21.1	A24376
Tamibarotene	Investigational	NCBP2	22916	downregulated	tamibarotene results in decreased expression of NCBP2 mRNA	3q29	A24376
Tamibarotene	Investigational	NCF1	653361	upregulated	tamibarotene results in increased expression of NCF1 mRNA	7q11.23	A24376
Tamibarotene	Investigational	NCOA6	23054	downregulated	tamibarotene results in decreased expression of NCOA6 mRNA	20q11.22	A24376
Tamibarotene	Investigational	NCOR2	9612	upregulated	tamibarotene results in increased expression of NCOR2 mRNA	12q24.31	A20516
Tamibarotene	Investigational	NEMP1	23306	downregulated	tamibarotene results in decreased expression of NEMP1 mRNA	12q13.3	A24376
Tamibarotene	Investigational	NFE2	4778	upregulated	tamibarotene results in increased expression of NFE2 mRNA	12q13	A24376

Displaying entries 76501 - 76525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability